So, as I read it, in the interim July results, 2 of 7 patients were clinical responders with the latest update, 3 of 10 being assessed as responders with stable brain volume. Of course, not massive numbers but good to see the continuation of the early trends from the July results.
with the 201 double blind results, if we get 30-40 responders from the 77 - with no adverse effects, we in business.
all imo
Ann: Alterity Data Presentations at MDS Congress Raises Profile, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $100.4M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.1¢ | 1.0¢ | $60.81K | 5.737M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 16255465 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 1643984 | 2 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| ATH (ASX) Chart |